(NAMS)

NewAmsterdam Pharma Company NV (NAMS) produces promising results
Kenneth Phillips
While NewAmsterdam Pharma Company NV has overperformed by 5.90%, investors are advised to look at stock chart patterns for technical ...

Is NewAmsterdam Pharma Company NV (NAMS) a good investment opportunity?
Arcelia Reed
While NewAmsterdam Pharma Company NV has overperformed by 8.41%, investors are advised to look at stock chart patterns for technical ...

A closer look at NewAmsterdam Pharma Company NV’s (NAMS) current quarter earnings projections
Cameron Mitchell
NewAmsterdam Pharma Company NV (NAMS)’s stock has witnessed a price hike of 1.58% from the previous close with its current ...